Nonarteritic anterior ischemic optic neuropathy treatments and current innovations Non-arteritik anterior iskemik optik nöropati tedavisi ve güncel yenilikler

KARTI Ö., Karahan E., Uyar M., Kusbeci T.

Retina-Vitreus, cilt.23, sa.3, ss.265-274, 2015 (Scopus, TRDizin) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 23 Sayı: 3
  • Basım Tarihi: 2015
  • Dergi Adı: Retina-Vitreus
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.265-274
  • Anahtar Kelimeler: Ischemia, Neuroprotection, Nonarteritic anterior ischaemic optic neuropathy, Steroid
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Nonarteritic anterior ischaemic optic neuropathy (NAION) is the most common acute opticneuropathy in people older than 50 years. The clinic condition is caused by infarction of the laminar or retrolaminar portion of the optic nerve head supplied by the short posterior ciliary arteries. The underlying aetiology and pathophysiology is poorly elucidated.Most treatments proposed for NAION are empirical and include a wide spectrum of agents presumed to effect on thrombosis, on the blood vessels, on the disc edema, or on the neuroprotection. Currently, there is no proven effective long-term treatment for this disorder. The aim of this review is to discuss the traditional treatment methods and current innovations in the nonarteritic ischemic optic neuropathy.